Saturday, September 30, 2023


Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design

Iktos, a company specialized in Artificial Intelligence for new drug design, announced a research collaboration with Zealand Pharma A/S, a biotechnology company changing lives...

Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy

Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care, announced...

Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific

Johnson & Johnson announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite Center) at Singapore's Duke-NUS Medical School, jointly...

Ionis Announces Eplontersen Met Co-primary and Secondary Endpoints in Interim Analysis of the Phase 3 NEURO-TTRansform Study

Ionis Pharmaceuticals, Inc. announced positive topline results from a 35-week interim analysis of the Phase 3 NEURO-TTRansform study of Ionis and AstraZeneca's eplontersen in...

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

Valneva SE, a specialty vaccine company, and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms...

Hot Topics